BiotechTube
Home/Clinuvel Pharmaceuticals/Bradford J. Dufton
BJ

Bradford J. Dufton

Company Secretary and Global Head of Corporate Services

Clinuvel Pharmaceuticals

Therapeutic Areas

DermatologyNeurology

Clinuvel Pharmaceuticals Pipeline

DrugIndicationPhase
SCENESSE® (afamelanotide)Erythropoietic Protoporphyria (EPP)Approved

Leadership Team at Clinuvel Pharmaceuticals

DP
Dr. Philippe Wolgen
Chief Executive Officer
DR
Derek R. H. Lamb
Chief Financial Officer
DD
Dr. Dennis Wright
Chief Scientific Officer
DH
Dr. Hank Mansbach
Chief Medical Officer
DL
Dr. Laura K. Ferraresso
Global Head of Legal and Corporate Affairs
SM
Stan McLiesh
Chair
View full Clinuvel Pharmaceuticals profile